These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30950571)

  • 41. Comprehensive Improvement of Sample Preparation Methodologies Facilitates Dynamic Metabolomics of Aspergillus niger.
    Zheng X; Yu J; Cairns TC; Zhang L; Zhang Z; Zhang Q; Zheng P; Sun J; Ma Y
    Biotechnol J; 2019 Mar; 14(3):e1800315. PubMed ID: 30144348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast cancer detection using targeted plasma metabolomics.
    Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-throughput metabolomics screen coupled with multivariate statistical analysis identifies therapeutic targets in alcoholic liver disease rats using liquid chromatography-mass spectrometry.
    Fang H; Zhang AH; Sun H; Yu JB; Wang L; Wang XJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1109():112-120. PubMed ID: 30743140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Strategies for large-scale targeted metabolomics quantification by liquid chromatography-mass spectrometry.
    Zhou J; Yin Y
    Analyst; 2016 Nov; 141(23):6362-6373. PubMed ID: 27722450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival.
    von Rundstedt FC; Rajapakshe K; Ma J; Arnold JM; Gohlke J; Putluri V; Krishnapuram R; Piyarathna DB; Lotan Y; Gödde D; Roth S; Störkel S; Levitt JM; Michailidis G; Sreekumar A; Lerner SP; Coarfa C; Putluri N
    J Urol; 2016 Jun; 195(6):1911-9. PubMed ID: 26802582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tuning Metabolome Coverage in Reversed Phase LC-MS Metabolomics of MeOH Extracted Samples Using the Reconstitution Solvent Composition.
    Lindahl A; Sääf S; Lehtiö J; Nordström A
    Anal Chem; 2017 Jul; 89(14):7356-7364. PubMed ID: 28613827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of peak-picking workflows for untargeted liquid chromatography/high-resolution mass spectrometry metabolomics data analysis.
    Rafiei A; Sleno L
    Rapid Commun Mass Spectrom; 2015 Jan; 29(1):119-27. PubMed ID: 25462372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simultaneous metabolomics and lipidomics analysis based on novel heart-cutting two-dimensional liquid chromatography-mass spectrometry.
    Wang S; Zhou L; Wang Z; Shi X; Xu G
    Anal Chim Acta; 2017 May; 966():34-40. PubMed ID: 28372724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolomics for searching validated biomarkers in cancer studies: a decade in review.
    López-López Á; López-Gonzálvez Á; Barbas C
    Expert Rev Mol Diagn; 2024 Jul; 24(7):601-626. PubMed ID: 38904089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tissue-Based Metabolomics to Analyze the Breast Cancer Metabolome.
    Budczies J; Denkert C
    Recent Results Cancer Res; 2016; 207():157-75. PubMed ID: 27557538
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alteration of intracellular metabolome in osteosarcoma stem cells revealed by liquid chromatography-tandem mass spectrometry.
    Zhong Z; Mao S; Lin H; Li H; Lin J; Lin JM
    Talanta; 2019 Nov; 204():6-12. PubMed ID: 31357340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Untargeted metabolomics.
    Vinayavekhin N; Saghatelian A
    Curr Protoc Mol Biol; 2010 Apr; Chapter 30():Unit 30.1.1-24. PubMed ID: 20373502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolomics of Vibrio cholerae.
    Minato Y; Kirkwood JS; Häse CC
    Methods Mol Biol; 2018; 1839():45-51. PubMed ID: 30047053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Data acquisition workflows in liquid chromatography coupled to high resolution mass spectrometry-based metabolomics: Where do we stand?
    Fenaille F; Barbier Saint-Hilaire P; Rousseau K; Junot C
    J Chromatogr A; 2017 Dec; 1526():1-12. PubMed ID: 29074071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liquid chromatography-mass spectrometric multiple reaction monitoring-based strategies for expanding targeted profiling towards quantitative metabolomics.
    Guo B; Chen B; Liu A; Zhu W; Yao S
    Curr Drug Metab; 2012 Nov; 13(9):1226-43. PubMed ID: 22519369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of culture media upon observed cell secretome metabolite profiles: The balance between cell viability and data interpretability.
    Daskalaki E; Pillon NJ; Krook A; Wheelock CE; Checa A
    Anal Chim Acta; 2018 Dec; 1037():338-350. PubMed ID: 30292310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolomics in pancreatic cancer biomarkers research.
    Tumas J; Kvederaviciute K; Petrulionis M; Kurlinkus B; Rimkus A; Sakalauskaite G; Cicenas J; Sileikis A
    Med Oncol; 2016 Dec; 33(12):133. PubMed ID: 27807722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a Liquid Chromatography-High Resolution Mass Spectrometry Metabolomics Method with High Specificity for Metabolite Identification Using All Ion Fragmentation Acquisition.
    Naz S; Gallart-Ayala H; Reinke SN; Mathon C; Blankley R; Chaleckis R; Wheelock CE
    Anal Chem; 2017 Aug; 89(15):7933-7942. PubMed ID: 28641411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New opportunities from the cancer metabolome.
    Aboud OA; Weiss RH
    Clin Chem; 2013 Jan; 59(1):138-46. PubMed ID: 23150057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improving metabolome coverage and data quality: advancing metabolomics and lipidomics for biomarker discovery.
    Vuckovic D
    Chem Commun (Camb); 2018 Jun; 54(50):6728-6749. PubMed ID: 29888773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.